Utilization and outcomes of HbA1c testing: A population-based study

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 3, 2006, Pages 327-329

  Woodward, Graham ^a   Van Walraven, Carl ^a,d   Hux, Janet E ^a,b,c  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCOSYLATION; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITAL SERVICE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; STATISTICAL ANALYSIS; AGE; CANADA; FACTUAL DATABASE; HEALTH SERVICE; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MASS SCREENING; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RETROSPECTIVE STUDY; UTILIZATION REVIEW;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; ONTARIO; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 32544440943     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1031433     Document Type: Article

References (14)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993,329:977-86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. Ic in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-8.
4. Burgers JS, Bailey JV, Klazinga NS, et al. Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 2002; 25:1933-9.
5. HUX JE, Tang M. Patterns of prevalence and incidence of diabetes. In: Diabetes in Ontario: a practice atlas. Toronto: Institute for Clinical Evaluative Sciences; 2003.
6. Van Walraven C, Raymond M, for the Network of Eastern Ontario Medical Laboratories. Population-based study of repeat laboratory testing. Clin Chem 2003:49: 1997-2005.
7. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25:512-6.
8. Meltzer S, Leiter L, Daneman D, et al; Canadian Diabetes Association. 1998 clinical practice guidelines for the management of diabetes in Canada [review]. CMAI 1998;159(6, Suppl 8):S1-29.
9. Worrall G, Freake D, Kelland J, et al. Care of patients with type II diabetes: a study of family physicians' compliance with clinical practice guidelines. J Fam Pract 1997;44:374-81.
10. Shorr RI, Franse LV, Resnick HE, et al. Glycemic control of older adults with type 2 diabetes: findings from the third National Health and Nutrition Examinadon Survey. J Am Geriatr Soc 2000;48:264-7.
11. Bell RA, Camacho F, Goonan K, et al. Quality of diabetes care among low-income patients in North Carolina. Am J Prev Med 2001;21:124-31.
12. Maclean JR, Fick DM, Hoffman WK, et al. Comparison of 2 systems for clinical practice profiling in diabetic care: medical records versus claims and administrative data. Am J Manag Care 2002;8:175-9.
13. Nichols GA, Hillier TA, Javor K, et al. Predictors of glycemic control in insulin using adults with type 2 diabetes. Diabetes Care 2000;23:273-7.
14. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002;25:1015-21.